Polycystic kidney disease: new knowledge and future promises.

Area of Science:

• Nephrology
• Genetics
• Molecular Biology

Background:

• Polycystic kidney disease (PKD) is a common genetic disorder leading to kidney failure.
• Current treatments primarily manage complications like hypertension, with limited disease-modifying options.
• Tolvaptan shows promise but has significant hepatic toxicity concerns.

Purpose of the Study:

• To review recent breakthroughs in understanding PKD.
• To highlight novel molecular and cellular mechanisms of renal cystogenesis.
• To discuss emerging therapeutic targets and stem cell applications for PKD.

Main Methods:

• Review of recent scientific literature on Polycystic Kidney Disease.
• Analysis of genetic, epigenetic, and mechanistic studies.
• Evaluation of current and novel therapeutic strategies.

Main Results:

• Identification of new genetic and epigenetic factors contributing to PKD.
• Improved understanding of the molecular pathways driving renal cyst formation.
• Emergence of novel therapeutic targets and stem cell-based approaches.

Conclusions:

• Recent advances are clarifying PKD pathogenesis, moving beyond symptom management.
• Novel therapeutic strategies targeting underlying mechanisms show significant promise.
• Stem cell technologies offer future potential for PKD treatment.